• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT XL VASCULAR STENT; VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT XL VASCULAR STENT; VASCULAR STENT SYSTEM Back to Search Results
Catalog Number EX061503C
Device Problems Loss of or Failure to Bond (1068); Break (1069); Difficult or Delayed Positioning (1157); Fracture (1260); Difficult to Remove (1528); Material Twisted/Bent (2981)
Patient Problem Stenosis (2263)
Event Date 08/17/2021
Event Type  Injury  
Manufacturer Narrative
The catalog number identified has not been cleared in the us but is similar to the lifestent vascular stent products that are cleared in the us.The pro code and 510 k number for the lifestent vascular stent products are identified.As the lot number for the device was provided, a review of the device history record is currently being performed.The return of the sample is pending.However, images were provided for review.The investigation of the reported event is currently underway.(expiry date: 02/2022).Device pending return.
 
Event Description
It was reported that during a stent placement procedure, the stent allegedly was difficult to advance.It was further reported that stent had difficulty in deploying and there was difficulty in removing the shaft.Reportedly stent was fractured and twisted.The procedure was completed using another device.Patient experienced mild stenosis in the region where the stent fractured.
 
Event Description
It was reported that during a stent placement procedure through femoral access site, the stent allegedly was difficult to advance.It was further reported that stent had difficulty in deploying and there was difficulty in removing the shaft.Reportedly stent was fractured and twisted.The procedure was completed using another device.Patient experienced mild stenosis in the region where the stent fractured.
 
Manufacturer Narrative
H10: the catalog number identified in section d4 has not been cleared in the us but is similar to the lifestent xl vascular stent products that are cleared in the us.The pro code and 510 k number for the lifestent xl vascular stent products are identified in d2 and g4.H10: manufacturing review: a review of manufacturing records was not performed, as additional complaints have not been reported for this lot.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.However, the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: the sample was returned for evaluation.The inner catheter was found detached from the system because an adhesive joint was found loose at the proximal end.Provided images further demonstrated hourglass like deformation of the stent inside the vessel which confirmed stent twisting.The returned system could not confirm difficult deployment, and stent fracture was not visible on the images.Therefore, the investigation leads to confirmed result for stent twisting, and inner catheter 'failure to bond' as cascading event.Based on the information available a definite root cause could not be identified.Labeling review: in reviewing the relevant labeling for this product the potential issue was found addressed.The instructions for use state: 'if excessive force is felt during stent deployment, do not force the delivery system.Remove the delivery system and replace with a new unit.', and 'gain femoral access utilizing a 6f (2.0 mm) or larger introducer sheath.(¿) insert a 0.035 inch (0.89 mm) diameter guidewire'.The instructions for use further state: 'predilation of the lesion should be performed using standard techniques.' in regards to resistance the instructions for use state: 'if resistance is met during delivery system introduction, the system should be removed and another system should be used.', and 'if resistance is met while retracting the delivery system over a guidewire, remove the delivery system and guidewire together.' h11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFESTENT XL VASCULAR STENT
Type of Device
VASCULAR STENT SYSTEM
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM  76227
Manufacturer (Section G)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM   76227
Manufacturer Contact
judy ludwig
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key12472694
MDR Text Key271453180
Report Number9681442-2021-00509
Device Sequence Number1
Product Code NIP
UDI-Device Identifier04049519001487
UDI-Public(01)04049519001487
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
P070014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,User Facility,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberEX061503C
Device Lot NumberANEP3020
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/13/2021
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/19/2021
Initial Date FDA Received09/15/2021
Supplement Dates Manufacturer Received02/28/2022
Supplement Dates FDA Received03/02/2022
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age66 YR
Patient SexFemale
-
-